drugset / Trial / NCT03029013

Apatinib and Chemotherapy Sequential Treatment With Cervical Cancer

NCT03029013

Unknown 30 enrolled Third Military Medical University
NaSingle-groupOpen-labelTreatment

Summary

The study is the single arm and single center clinical trials,We conduct the phase II clinical trial to further explore the efficacy and safety of Apatinib and chemotherapy sequential treatment with advanced recurrence of metastatic cervical cancer

Timeline

Start
2017-01
Primary completion
2019-12
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Rivoceranib Small molecule 250 mg Oral

Indications